Paul Kohlhaas of Molecule & VitaDAO - how Crypto, NFTs, & DAOs can fund Longevity and Psychedelics

💰Invest in Brom's Psychedelic VC Fund:

Paul Kohlhaas is the cofounder of Molecule ( ) a collaborative platform where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients.  He is also the co-initiator of VitaDAO ( ), a decentralized collective funding early stage longevity research.

In this episode we discuss the exciting intersection of crypto and biotech, and how DAOs might replace some of the traditional funding mechanisms of scientific research.  

⭐️ Become an Integration Insider and get early access to episodes:

📝 My notes on psychedelic investing:

🎧 Listen on Spotify and other podcast platforms:

🐦 brom on twitter:

🎇 Clips and other stuff on Instagram:

💌 Email: